Next Article in Journal
Peptides to Overcome the Limitations of Current Anticancer and Antimicrobial Nanotherapies
Next Article in Special Issue
Treatment of Neuronopathic Mucopolysaccharidoses with Blood–Brain Barrier-Crossing Enzymes: Clinical Application of Receptor-Mediated Transcytosis
Previous Article in Journal
Prevention of Ulcerative Colitis by Autologous Metabolite Transfer from Colitogenic Microbiota Treated with Lipid Nanoparticles Encapsulating an Anti-Inflammatory Drug Candidate
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(6), 1234; https://doi.org/10.3390/pharmaceutics14061234
Action Date Notes Link
article pdf uploaded. 10 June 2022 14:54 CEST Version of Record https://www.mdpi.com/1999-4923/14/6/1234/pdf-vor
article xml file uploaded 14 June 2022 14:31 CEST Original file -
article xml uploaded. 14 June 2022 14:31 CEST Update https://www.mdpi.com/1999-4923/14/6/1234/xml
article pdf uploaded. 14 June 2022 14:31 CEST Updated version of record https://www.mdpi.com/1999-4923/14/6/1234/pdf
article html file updated 14 June 2022 14:33 CEST Original file https://www.mdpi.com/1999-4923/14/6/1234/html
Back to TopTop